Rockville, November 3-- An experimental drug for lupus, named Benlysta, has passed the last stage of testing at a higher dose and will now be sent to the Food and Drug Administration (FDA) for its approval, Rockville-based Human Genome Sciences (HGS) revealed on Monday.